Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Aug 01, 2024

BUY
$8.16 - $13.13 $1.81 Million - $2.91 Million
221,678 New
221,678 $2.76 Million
Q4 2023

Feb 07, 2024

BUY
$8.16 - $13.13 $116,606 - $187,627
14,290 Added 6.89%
221,678 $2.76 Million
Q3 2023

Aug 01, 2024

BUY
$12.15 - $18.33 $2.52 Million - $3.8 Million
207,388 New
207,388 $2.6 Million
Q3 2023

Oct 26, 2023

BUY
$12.15 - $18.33 $2.52 Million - $3.8 Million
207,388 New
207,388 $2.6 Million
Q2 2022

Aug 05, 2022

SELL
$12.76 - $19.97 $1.64 Million - $2.56 Million
-128,333 Reduced 62.09%
78,368 $1.24 Million
Q1 2022

Apr 19, 2022

BUY
$13.91 - $18.98 $1.11 Million - $1.51 Million
79,463 Added 62.45%
206,701 $3.46 Million
Q4 2021

Jan 28, 2022

BUY
$13.33 - $25.09 $1.7 Million - $3.19 Million
127,238 New
127,238 $2.25 Million

Others Institutions Holding FNA

About Paragon 28, Inc.


  • Ticker FNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 76,775,800
  • Market Cap $795M
  • Description
  • Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navic...
More about FNA
Track This Portfolio

Track Roubaix Capital, LLC Portfolio

Follow Roubaix Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roubaix Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Roubaix Capital, LLC with notifications on news.